Hurried safety reviews could miss drug side-effects

2019-03-02 04:03:00

SOME of the sweetest success stories for US drug companies have turned sour in recent years: Avandia and Vioxx have both been linked to an increased risk of heart attack, for example. Are hurried drug safety reviews part of the problem? Under the 1992 Prescription Drug User Fee Act,